Keyword: AstraZeneca


AstraZeneca Withdraws US Vaxzevria Launch Plan

16.11.2022 -

AstraZeneca (AZ) has announced it is permanently backing away from any plans to sell its Vaxzevria-branded Covid-19 vaccine in the US.


Pharma CEOs Take Action on Climate Change

08.11.2022 -

The CEOs of seven multinational pharmaceutical companies have announced that they are taking joint action to achieve near-term emissions reduction targets and accelerate...


EU Public Prosecutor Probes Vaccine Mega Order

20.10.2022 -

The European Public Prosecutors Office (EPPO) has confirmed that it is looking into the EU Commission’s ordering of Covid-19 vaccines, with the probe thought to pertain...


Alexion Strengthens Genomics with LogicBio Buy

06.10.2022 -

AstraZeneca’s rare disease arm Alexion has agreed to acquire LogicBio, a US clinical-stage specialist in genomic medicines.


GSK Names Julie Brown as First Female CFO

30.09.2022 -

From next year, GSK’s top management will be led by a double female team, a pioneering move for the global pharmaceutical industry. The UK drugs giant this week announced...


AstraZeneca CEO Goes “Off Message” on Covid Boosters

02.09.2022 -

Days before the FDA approved the new bivalent Covid-19 vaccine boosters, Pascal Soriot, CEO of AstraZeneca, offered his own assessment of the need for such.


FDA Restricts Use of J&J Covid Vaccine

13.05.2022 -

US health authorities are restricting the use of the Johnson & Johnson Covid vaccine somewhat belatedly, citing the rare blood clotting issues that have dogged this...

Chemistry & Life Sciences

Where Science Meets Business

19.04.2022 -

From its inception in 1881, SCI's principal objective has been to further the application of chemistry and related sciences into industry for the public benefit.